Lis, Christian <br/><br/>
Development of Erasin: a chromone-based STAT3 inhibitor which induces apoptosis in Erlotinib-resistant lung cancer cells.  [electronic resource] 

 -  Scientific reports  12 2017 
 - 17390 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/s41598-017-17600-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cell Line, Tumor<br/>Chromones--pharmacology<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Molecular Docking Simulation<br/>Phosphorylation<br/>Protein Processing, Post-Translational<br/>STAT1 Transcription Factor--antagonists & inhibitors<br/>STAT3 Transcription Factor--antagonists & inhibitors<br/>STAT5 Transcription Factor--antagonists & inhibitors<br/>Structure-Activity Relationship<br/>Tumor Suppressor Proteins--antagonists & inhibitors<br/>src Homology Domains